BACKGROUND: There is growing evidence that environmental peanut exposure through non-oral routes, including the skin and respiratory tract, can result in peanut sensitization. Environmental adjuvants in indoor dust can promote sensitization to inhaled antigens, but whether they contribute to peanut allergy development is unclear. OBJECTIVE: We investigated whether indoor dust promotes airway sensitization to peanut and peanut allergy development in mice. METHODS: Female and male C57BL/6J mice were exposed via the airways to peanut, indoor dust extract, or both for 2 weeks. Mice were then challenged with peanut and assessed for anaphylaxis. Peanut-specific immunoglobulins, peanut uptake by lung conventional dendritic cells (cDCs), lung innate cytokines, and T cell differentiation in lung-draining lymph nodes were quantified. Innate cytokine production by primary human bronchial epithelial cells exposed to indoor dust was also determined. RESULTS: Inhalational exposure to low levels of peanut in combination with indoor dust, but neither alone, resulted in production of peanut-specific IgE and development of anaphylaxis upon peanut challenge. Indoor dust triggered production of innate cytokines in murine lungs and in primary human bronchial epithelial cells. Additionally, inhaled indoor dust stimulated maturation and migration of peanut-laden lung type 1 cDCs to draining lymph nodes. Inhalational exposure to peanut and indoor dust induced peanut-specific T helper 2 cell differentiation and accumulation of T follicular helper cells in draining lymph nodes, which were associated with increased B cell numbers and peanut-specific immunoglobulin production. CONCLUSIONS & CLINICAL RELEVANCE: Indoor dust promotes airway sensitization to peanut and development of peanut allergy in mice. Our findings suggest that environmental adjuvants in indoor dust may be determinants of peanut allergy development in children.
BACKGROUND: There is growing evidence that environmental peanut exposure through non-oral routes, including the skin and respiratory tract, can result in peanut sensitization. Environmental adjuvants in indoor dust can promote sensitization to inhaled antigens, but whether they contribute to peanutallergy development is unclear. OBJECTIVE: We investigated whether indoor dust promotes airway sensitization to peanut and peanutallergy development in mice. METHODS: Female and male C57BL/6J mice were exposed via the airways to peanut, indoor dust extract, or both for 2 weeks. Mice were then challenged with peanut and assessed for anaphylaxis. Peanut-specific immunoglobulins, peanut uptake by lung conventional dendritic cells (cDCs), lung innate cytokines, and T cell differentiation in lung-draining lymph nodes were quantified. Innate cytokine production by primary human bronchial epithelial cells exposed to indoor dust was also determined. RESULTS: Inhalational exposure to low levels of peanut in combination with indoor dust, but neither alone, resulted in production of peanut-specific IgE and development of anaphylaxis upon peanut challenge. Indoor dust triggered production of innate cytokines in murine lungs and in primary human bronchial epithelial cells. Additionally, inhaled indoor dust stimulated maturation and migration of peanut-laden lung type 1 cDCs to draining lymph nodes. Inhalational exposure to peanut and indoor dust induced peanut-specific T helper 2 cell differentiation and accumulation of T follicular helper cells in draining lymph nodes, which were associated with increased B cell numbers and peanut-specific immunoglobulin production. CONCLUSIONS & CLINICAL RELEVANCE: Indoor dust promotes airway sensitization to peanut and development of peanutallergy in mice. Our findings suggest that environmental adjuvants in indoor dust may be determinants of peanutallergy development in children.
Authors: Timothy P Moran; Keiko Nakano; Gregory S Whitehead; Seddon Y Thomas; Donald N Cook; Hideki Nakano Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-09-18 Impact factor: 5.464
Authors: Glenda Batzer; Diane P Lam; Petra Paulus; Jared Boasen; Nicholas Ng; Anthony A Horner Journal: Immunobiology Date: 2007-04-30 Impact factor: 3.144
Authors: Haejin Kim; Kevin Tse; Linda Levin; David Bernstein; Tiina Reponen; Grace LeMasters; Zana Lummus; Anthony A Horner Journal: J Allergy Clin Immunol Date: 2012-03-03 Impact factor: 10.793
Authors: Gregory S Whitehead; Seddon Y Thomas; Karim H Shalaby; Keiko Nakano; Timothy P Moran; James M Ward; Gordon P Flake; Hideki Nakano; Donald N Cook Journal: J Clin Invest Date: 2017-07-31 Impact factor: 14.808
Authors: Rhonda H Wilson; Shuichiro Maruoka; Gregory S Whitehead; Julie F Foley; Gordon P Flake; Michelle L Sever; Darryl C Zeldin; Monica Kraft; Stavros Garantziotis; Hideki Nakano; Donald N Cook Journal: Nat Med Date: 2012-10-14 Impact factor: 53.440
Authors: Delicia Shu-Qin Ooi; Cheryl Pei-Ting Tan; Michelle Jia-Yu Tay; Siong Gim Ong; Elizabeth Huiwen Tham; Kewin Tien Ho Siah; Johan Gunnar Eriksson; Keith M Godfrey; Lynette Pei-Chi Shek; Evelyn Xiu-Ling Loo Journal: J Dev Orig Health Dis Date: 2020-06-15 Impact factor: 2.401
Authors: Johanna M Smeekens; Robert M Immormino; Michael D Kulis; Timothy P Moran Journal: J Allergy Clin Immunol Date: 2020-09-24 Impact factor: 10.793
Authors: Johanna M Smeekens; Brandi T Johnson-Weaver; Andrew L Hinton; M Andrea Azcarate-Peril; Timothy P Moran; Robert M Immormino; Janelle R Kesselring; Erin C Steinbach; Kelly A Orgel; Herman F Staats; A Wesley Burks; Peter J Mucha; Martin T Ferris; Michael D Kulis Journal: Front Immunol Date: 2021-01-19 Impact factor: 7.561
Authors: Michael D Kulis; Johanna M Smeekens; Robert M Immormino; Timothy P Moran Journal: J Allergy Clin Immunol Date: 2021-06-07 Impact factor: 14.290